Zdrowie i gospodarka · 10/12/2021
FDA Releases Draft Guidance for Industry on Chronic Rhinosinusitis with Nasal Polyps Treatment
The FDA has published a draft guidance to help pharmaceutical companies develop effective treatments for chronic rhinosinusitis with nasal polyps, outlining trial design, safety, and efficacy considerations for clinical trials
Source: Federal Register — Food and Drug AdministrationOpen original release →